Filing Details

Accession Number:
0001179110-13-012267
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-30 11:40:01
Reporting Period:
2013-07-26
Filing Date:
2013-07-30
Accepted Time:
2013-07-30 11:40:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1294354 P Richard Shea C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
Svp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-07-26 30,000 $16.61 150,316 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase stock Acquisiton 2013-07-26 30,000 $0.61 30,000 $0.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
211,578 2007-10-28 2013-10-28 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2012.